InnoCare Pharma Statistics

Total Valuation

InnoCare Pharma has a market cap or net worth of CNY 18.86 billion. The enterprise value is 13.50 billion.

Market Cap	18.86B
Enterprise Value	13.50B

Important Dates

The next estimated earnings date is Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.67%
Shares Change (QoQ)	-14.59%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.38B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.68
PB Ratio	2.80
P/TBV Ratio	2.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-30.65
EV / Sales	13.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.43

Financial Position

The company has a current ratio of 7.45, with a Debt / Equity ratio of 0.23.

Current Ratio	7.45
Quick Ratio	7.01
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	-3.55
Interest Coverage	-16.12

Financial Efficiency

Return on equity (ROE) is -6.50% and return on invested capital (ROIC) is -3.97%.

Return on Equity (ROE)	-6.50%
Return on Assets (ROA)	-3.52%
Return on Invested Capital (ROIC)	-3.97%
Return on Capital Employed (ROCE)	-6.52%
Revenue Per Employee	926,950
Profits Per Employee	-404,622
Employee Count	1,089
Asset Turnover	0.10
Inventory Turnover	1.29

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +129.78% in the last 52 weeks. The beta is 0.96, so InnoCare Pharma's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+129.78%
50-Day Moving Average	18.49
200-Day Moving Average	13.49
Relative Strength Index (RSI)	58.44
Average Volume (20 Days)	5,996,405

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, InnoCare Pharma had revenue of CNY 1.01 billion and -440.63 million in losses. Loss per share was -0.26.

Revenue	1.01B
Gross Profit	871.01M
Operating Income	-544.71M
Pretax Income	-452.59M
Net Income	-440.63M
EBITDA	-477.69M
EBIT	-544.71M
Loss Per Share	-0.26

Full Income Statement

Balance Sheet

The company has 7.00 billion in cash and 1.57 billion in debt, giving a net cash position of 5.43 billion.

Cash & Cash Equivalents	7.00B
Total Debt	1.57B
Net Cash	5.43B
Net Cash Per Share	n/a
Equity (Book Value)	6.75B
Book Value Per Share	3.82
Working Capital	6.77B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -365.55 million and capital expenditures -78.23 million, giving a free cash flow of -443.78 million.

Operating Cash Flow	-365.55M
Capital Expenditures	-78.23M
Free Cash Flow	-443.78M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 86.29%, with operating and profit margins of -53.96% and -43.65%.

Gross Margin	86.29%
Operating Margin	-53.96%
Pretax Margin	-44.84%
Profit Margin	-43.65%
EBITDA Margin	-47.32%
EBIT Margin	-53.96%
FCF Margin	n/a

Dividends & Yields

InnoCare Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.67%
Shareholder Yield	0.67%
Earnings Yield	-2.34%
FCF Yield	-2.35%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

InnoCare Pharma has an Altman Z-Score of 2.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.25
Piotroski F-Score	n/a